Effect of mastitis during the first lactation on production and reproduction performance of Holstein cows

Moussavi, Alireza Heravi; Mesgaran, M. Danesh; Gilbert, R.O.

doi:10.1007/s11250-012-0107-3

Cited by 12 publications

(12 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Because exact information could not be confirmed after multiple attempts to contact the authors, this manuscript was excluded. For 8 manuscripts (Vaarst and Enevoldsen, 1997;Sviland and Waage, 2002;Gasqui et al, 2003;Heringstad et al, 2006;Wolfová et al, 2006;Wolf et al, 2010;Heravi Moussavi et al, 2012;Oliveira et al, 2013), ancillary information regarding CM description (e.g., number of cow lactations or cow days followed) was missing. Authors of the 8 manuscripts were contacted and asked to provide the needed information; this information was obtained for 3 manuscripts (Sviland and Waage, 2002;Gasqui et al, 2003;Heringstad et al, 2006) and was not available for 1 manuscript (Oliveira et al, 2013), and an answer from the authors could not be obtained for 4 manuscripts (Vaarst et al, 2002;Wolfová et al, 2006;Wolf et al, 2010;Heravi Moussavi et al, 2012).…”

Section: Resultsmentioning

confidence: 99%

“…In 4 studies (Rajala and Gröhn, 1998;Sviland and Waage, 2002;Monti and de Jong, 2005;Pérez-Cabal et al, 2009), CM data were obtained from existing databases; all other studies used prospective CM data collection. Regarding the minimal lag time between CM episodes to consider them as independent episodes, 3 studies (Gasqui et al, 2003;Pérez-Cabal et al, 2009;Heravi Moussavi et al, 2012) used a minimum of only 1 d between CM episodes in their case definition. Minimal number of days between CM events used in the other studies ranged from 5 d (Wolf et al, 2010) to 21 d (Rajala and Gröhn, 1998).…”

Section: Systematic Review and Meta-analysis On Risk Of CM Recurrencementioning

confidence: 99%

See 1 more Smart Citation

Invited review: Incidence, risk factors, and effects of clinical mastitis recurrence in dairy cows

Jamali

Barkema

Jacques

et al. 2018

Journal of Dairy Science

117

View full text Add to dashboard Cite

Clinical mastitis (CM) is one of the most frequent and costly diseases in dairy cows. A frustrating aspect of CM is its recurrent nature. This review was conducted to synthesize knowledge on risk of repeated cases of CM, effects of recurrent CM cases, and risk factors for CM recurrence. A systematic review methodology was used to identify articles for this narrative review. Searches were performed to identify relevant scientific literature published after 1989 in English or French from 2 databases (PubMed and CAB Abstracts) and 1 search platform (Web of Science). Fifty-seven manuscripts were selected for qualitative synthesis according to the inclusion criteria. Among the 57 manuscripts selected in this review, a description of CM recurrence, its risk factors, and effects were investigated and reported in 33, 37, and 19 selected manuscripts, respectively. Meta-analysis and meta-regression analyses were used to compute risk ratio comparing risk of CM in cows that already had 1 CM event in the current lactation with risk of CM in healthy cows. For these analyses, 9 manuscripts that reported the total number of lactations followed and the number of lactations with ≤1 and ≤2 CM cases were used. When summarizing results from studies requiring ≥5 d between CM events to consider a CM event as a new case, we observed no significant change in CM susceptibility following a first CM case (risk ratio: 0.99; 95% confidence interval: 0.86-1.14). However, for studies using a more liberal CM recurrence definition (i.e., only 24 h between CM events to consider new CM cases), we observed a 1.54 times greater CM risk (95% confidence interval: 1.20-1.97) for cows that already had 1 CM event in the current lactation compared with healthy cows. The most important risk factors for CM recurrence were parity (i.e., higher risk in older cows), a higher milk production, pathogen species involved in the preceding case, and whether a bacteriological cure was observed following the preceding case. The most important effects of recurrent CM were the milk yield reduction following a recurrent CM case, which was reported to be similar to that of the first CM case, and the increased risk of culling and mortality, which were reported to surpass those of first CM cases.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Systematic Review and Meta-analysis On Risk Of CM Recurrencementioning

confidence: 99%

Invited review: Incidence, risk factors, and effects of clinical mastitis recurrence in dairy cows

Jamali

Barkema

Jacques

et al. 2018

Journal of Dairy Science

117

View full text Add to dashboard Cite

show abstract

“…Moussavi et al . [25] reported that more episodes of mastitis in early lactation significantly increased the SC with no apparent impact on the DO. Interestingly, we also observed that cows in the first and second parities diagnosed with CM had significantly delayed DTFDH.…”

Section: Discussionmentioning

confidence: 99%

Influence of clinical mastitis and its treatment outcome on reproductive performance in crossbred cows: A retrospective study

Kumar¹,

Manimaran²,

Sivaram³

et al. 2017

Vet World

View full text Add to dashboard Cite

Aim:Evaluation of the effect of clinical mastitis (CM) and its treatment outcome on the reproductive performance in crossbred cows retrospectively.Materials and Methods:Datasets of 835 lactating cows affected with CM during a period of 12 years (2001-2012) were considered for this study. Mastitis treatment related data and reproductive parameters such as days to first detected heat (DTFDH), days to first insemination (DTFI), days open (DO), and number of services per conception (SC) were collected from mastitis treatment and artificial insemination registers, respectively. Data were analyzed by ANOVA using SPSS 20 software. The means were compared with the Duncan’s multiple comparison post-hoc test.Results:CM affected cows had significantly (p<0.05) higher DTFDH, DTFI, DO and SC compared to clinically healthy cows. Cows diagnosed with a single episode of CM had significantly (p<0.05) delayed DTFDH while, DO and SC were significantly higher (p<0.05) in cows diagnosed by multiple episodes of CM. SC was significantly (p<0.05) higher in cows diagnosed with both relapse and recurrence. Severe CM affected cows had significantly (p<0.05) altered reproductive parameters. The reproductive parameters were altered to high extent when CM occurred during the breeding period.Conclusion:CM-affected cows had higher DTFDH, DTFI, DO and SC compared to clinically healthy cows. The negative effects of CM on reproduction parameters were higher when CM occurred during the breeding period.

show abstract

“…Indeed, in vitro studies developed in cattle have shown the anti-inflammatory effect of meloxicam in mammary epithelial cells (25). Furthermore, mastitis in cows has been associated with reduced pre-weaning immunity, growth, and health of the offspring (26,27), so the anti-inflammatory effect elicited by meloxicam treatment is presumed to have the opposite effect.…”

Section: Transfer Of Passive and Active Immunitymentioning

confidence: 99%

Oral Meloxicam Administration in Sows at Farrowing and Its Effects on Piglet Immunity Transfer and Growth

et al. 2021

View full text Add to dashboard Cite

Many factors can lead to an inadequate development of piglets during their first days of life, including poor maternal behavior, which can be due to pain caused by farrowing, and reduced colostrum ingestion. This study investigates the action of meloxicam administered orally at farrowing on piglet weight gain and immunity transfer. Thirty-five multiparous sows were divided into two groups and treated with 0.4 mg/kg of oral meloxicam (oral meloxicam group; n = 18) or with a mock administration (control group; n = 17). A total of 382 piglets were individually weighed on the farrowing day (day 0), as well as on days +9 and +20. Immunoglobulin G (IgG) and A (IgA) concentrations in piglet serum and in sow's saliva, colostrum and milk were measured. Additionally, Interleukin-2 (IL-2), Interleukin-4 (IL-4) and Interferon gamma (IFN-⋎) in serum of piglets and in sow's milk or colostrum were studied. All samples were obtained on days +1, +9, and +20. Piglets from sows in the oral meloxicam group tended to grow faster from day +9 to day +20 than did piglets from control sows (p = 0.059), and this difference was also observed in piglets with low body weight (BW) at birth (p = 0.056). The oral meloxicam group sows tended to increase the colostrum levels of IgA and IgG, as compared with control sows on day +1 (p = 0.068 and p = 0.072, respectively). IgA levels in piglet serum from the oral meloxicam group were significantly higher than in the control group on day +1 and +9 (p = 0.019 and p = 0.011 respectively). Furthermore, IL-2 and IL-4 levels in the serum of piglets from sows in the oral meloxicam group tended to be higher than that in the control group on day +9 (p = 0.078 and 0.056, respectively). The administration of meloxicam orally at the beginning of farrowing in multiparous sows increased immunoglobin and cytokine concentrations in colostrum, improving both humoral and cellular immune response of piglets. Pre-weaning growth of piglets born with a low BW improved in the meloxicam-treated group.

show abstract

Effect of mastitis during the first lactation on production and reproduction performance of Holstein cows

Cited by 12 publications

References 21 publications

Invited review: Incidence, risk factors, and effects of clinical mastitis recurrence in dairy cows

Invited review: Incidence, risk factors, and effects of clinical mastitis recurrence in dairy cows

Influence of clinical mastitis and its treatment outcome on reproductive performance in crossbred cows: A retrospective study

Oral Meloxicam Administration in Sows at Farrowing and Its Effects on Piglet Immunity Transfer and Growth

Contact Info

Product

Resources

About